Objective: To observe the effects of Yunqi decoction (匀气汤, YQD) on both esophageal mucosal morphology and esophageal motility in patients with reflux esophagitis (RE). Methods: According to syndrome differentiation...Objective: To observe the effects of Yunqi decoction (匀气汤, YQD) on both esophageal mucosal morphology and esophageal motility in patients with reflux esophagitis (RE). Methods: According to syndrome differentiation of traditional Chinese medicine (TCM), 42 RE patients were divided into three groups fdisharmony of Liver and Stomach (group D), Deficiency-Cold of Spleen and Stomach (Group DC), Heat Syndrome caused by stagnation of Liver Qi (Group H). No. Ⅰ, Ⅱ, Ⅲ of YQD were taken respectively for 4 weeks.Before and after treatment scores of typical symptoms were collected, gastroscopy was performed and esophagealmotility were measured. Results: (1 ) The symptom remission rate was 81. 1 %, there were significant differences between the group DC with group D and group H (P< 0. 01 ). (2) The esophageal mucosal healing ratewas 61. 9 %, the effective rate was 90. 5 %, and the ineffective rate was 9. 5 %. There were not significant differences of effective rate among the three groups (P > 0. 05). (3) The changes of esophageal motility: Loweresophageal sphincter pressure (LESP) and average peristaltic pressure (APP) of group D were obviously higherthan before treatment (P < 0. 05), LESP, gastro--esophageal barrier pressure (GEBP) and peristaltic conductspeed (PCS) of group DC were remarkably higher (P < 0. 05). GEBP of group H was improved (P < 0. 05 ).Conclusions: YQD has a good therapeutic effect. It's not only resolving reflux esophageal symptoms, healingesophageal mucosa, but also improving esophageal motile function.展开更多
文摘Objective: To observe the effects of Yunqi decoction (匀气汤, YQD) on both esophageal mucosal morphology and esophageal motility in patients with reflux esophagitis (RE). Methods: According to syndrome differentiation of traditional Chinese medicine (TCM), 42 RE patients were divided into three groups fdisharmony of Liver and Stomach (group D), Deficiency-Cold of Spleen and Stomach (Group DC), Heat Syndrome caused by stagnation of Liver Qi (Group H). No. Ⅰ, Ⅱ, Ⅲ of YQD were taken respectively for 4 weeks.Before and after treatment scores of typical symptoms were collected, gastroscopy was performed and esophagealmotility were measured. Results: (1 ) The symptom remission rate was 81. 1 %, there were significant differences between the group DC with group D and group H (P< 0. 01 ). (2) The esophageal mucosal healing ratewas 61. 9 %, the effective rate was 90. 5 %, and the ineffective rate was 9. 5 %. There were not significant differences of effective rate among the three groups (P > 0. 05). (3) The changes of esophageal motility: Loweresophageal sphincter pressure (LESP) and average peristaltic pressure (APP) of group D were obviously higherthan before treatment (P < 0. 05), LESP, gastro--esophageal barrier pressure (GEBP) and peristaltic conductspeed (PCS) of group DC were remarkably higher (P < 0. 05). GEBP of group H was improved (P < 0. 05 ).Conclusions: YQD has a good therapeutic effect. It's not only resolving reflux esophageal symptoms, healingesophageal mucosa, but also improving esophageal motile function.
